BioElectronics Corp. Merits a First Look
Most investors won’t touch a stock trading on the pink sheets with a ten foot medical device. But for the risk-inclined among you, BioElectronics Corp. […]
Blog
[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical
Bioject Medical develops and markets needle-free injection technology used to administer injectable medications. Bioject’s technology works by forcing liquid medication at high speed through a […]
Bad News for Blood Substitutes
Blood substitutes don’t require refrigeration or cross-matching, have a long shelf life, and reduce the risk of iatrogenic infection. They could be a potentially lifesaving […]
CryoLife on Firm Footing: EPS Increases, Revenues Up, Raises Guidance
Revenues at CryoLife rose 4% to $25.6 million in the first quarter of 2008. Net income was $2.8 million, or $0.10 per share, compared to […]
NeuroMetrix Receives FDA 510(k) Clearance for Advance
Long beleaguered NeuroMetrix, which has seen its stock price erode as officials investigate the marketing and misuse of its NC-stat System, received FDA 510(k) clearance […]
[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on a novel approach to the […]
Merit Medical: Shows Resilience in Faltering Economy; Positioned for Continued Growth
The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade and appears to be holding […]
Yulex Receives FDA 510(k) Clearence for Novel Rubber Glove
Latex glove use increased dramatically in the eighties largely as an outgrowth of the AIDS epidemic. Almost unheard of 20 years ago, researchers now estimate […]
Biophan Moves Forward with Myotech CSS Development
Pittsford, NY-based Biophan Technologies, will move forward with the next phase of the Myotech Circulatory Support System (CSS) engineering and regulatory development program. The company’s […]
OccuLogix Looks to Tears, Hopes to Survive Difficulties
OccuLogix, which traded as high as $1.63 just one year ago, has seen its share price erode as investors lose confidence in the company and […]